The principal objective of this work is to design isozyme-specific activator/inhibitors of protein kinase C (PK-C) capable of binding selectively to the regulatory, C1 domain of PK-C isozymes and other families of transducing enzymes with structurally similar C1 domains. The main synthetic effort is to design, simple and chemically accessible compounds that are structurally related to the natural PK-C agonist, the second messenger diacylglycerol (DAG). A combinatorial approach that utilizes a 4,4-disubstituted-gamma-butyrolactone template as a conformationally rigid DAG scaffold (DAG-lactones) was implemented to investigate the best combination of alkyl and acyl chains to improve hydrophobic interactions with a group of highly conserved hydrophobic amino acids along the rim of the C1 domain (e.g., the Phe-243, Leu-250, Trp-252 and Leu-254 in PK-Cdelta). The combination of linear and branched chains produced a large library of compounds where optimal ligands reached namolar binding affinities. The best compound yet discovered, (Z)-{1-(Hydroxymethyl)-4-[4-methyl-3- (methylethyl)pentylidene]-3-oxo-2-oxolanyl}methyl 4-methyl-3- (methylethyl)pentanoate, is a doubly branched DAG-lactone with low namomolar (ca. 2 nM) binding affinity for PK-C. This compound showed potent and selective antitumor activity in the NCI 60-cell line in vitro screen against specific breast, colon and leukemia cell lines at low nanomolar concentrations. Besides binding to the C1 domains of the classical and novel members of PK-C isozymes, DAG and the phorbol esters are also able to bind to the C1 domain(s) in other families of proteins involved in signal transduction, namely PKD, the chimaerins and RasGRP. The compound described above is the first compound ever to surpass phorbol ester in potency (subnanomolar Ki) and selectivity (3- fold) for the C1 domain of beta2-chimaerin. Chimaerins do not possess a functional kinase domain but they are GTPase-activating proteins (GAP) for Rac, a small GTP binding protein of the Ras superfamily. The combinatorial chemical approach described here, coupled to intensive molecular modeling and docking studies of the different C1 domains, bodes well for the future design of specific C1-domain-targeted ligands with promising antitumor activity. - molecular models receptors, phorbol Esters, protein kinase C cell signalling, Zinc fingers,

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01BC006176-14
Application #
6289177
Study Section
Special Emphasis Panel (LMC)
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1999
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Kikuchi, Junko; Takashina, Taichi; Kinoshita, Ichiro et al. (2012) Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer 78:138-43
Comin, Maria J; Czifra, Gabriella; Kedei, Noemi et al. (2009) Conformationally constrained analogues of diacylglycerol (DAG). 31. Modulation of the biological properties of diacylgycerol lactones (DAG-lactones) containing rigid-rod acyl groups separated from the core lactone by spacer units of different lengths. J Med Chem 52:3274-83
Byun, Hyang-Min; Choi, Si Ho; Laird, Peter W et al. (2008) 2'-Deoxy-N4-[2-(4-nitrophenyl)ethoxycarbonyl]-5-azacytidine: a novel inhibitor of DNA methyltransferase that requires activation by human carboxylesterase 1. Cancer Lett 266:238-48
Yoo, Christine B; Valente, Rocco; Congiatu, Costantino et al. (2008) Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine. J Med Chem 51:7593-601
Philosof-Mazor, Liron; Volinsky, Roman; Comin, Maria J et al. (2008) Self-assembly and lipid interactions of diacylglycerol lactone derivatives studied at the air/water interface. Langmuir 24:11043-52
Ludek, Olaf R; Schroeder, Gottfried K; Wolfenden, Richard et al. (2008) Synthesis of conformationally locked carbocyclic 1,3-diazepinone nucleosides as inhibitors of cytidine deaminase. Nucleic Acids Symp Ser (Oxf) :659-60
Malolanarasimhan, Krishnan; Kedei, Noemi; Sigano, Dina M et al. (2007) Conformationally constrained analogues of diacylglycerol (DAG). 27. Modulation of membrane translocation of protein kinase C (PKC) isozymes alpha and delta by diacylglycerol lactones (DAG-lactones) containing rigid-rod acyl groups. J Med Chem 50:962-78
Kang, Ji-Hye; Benzaria, Samira; Sigano, Dina M et al. (2006) Conformationally constrained analogues of diacylglycerol. 26. Exploring the chemical space surrounding the C1 domain of protein kinase C with DAG-lactones containing aryl groups at the sn-1 and sn-2 positions. J Med Chem 49:3185-203
Lee, Jeewoo; Kang, Ji-Hye; Han, Kee-Chung et al. (2006) Branched diacylglycerol-lactones as potent protein kinase C ligands and alpha-secretase activators. J Med Chem 49:2028-36
Jorgensen, Rene; Merrill, A Rod; Yates, Susan P et al. (2005) Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry. Nature 436:979-84

Showing the most recent 10 out of 36 publications